49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) Conference

Scholarly Activity

related documents

A dose-escalation phase I study of a first-in-class cancer stemness inhibitor in patients with advanced malignancies Conferences
A multicenter open-label phase II study of the efficacy and safety of ganitumab (AMG 479), a fully human monoclonal antibody against insulin-like growth factor type 1 receptor (IGF-1R) as second-line therapy in patients with recurrent platinum-sensitive ovarian cancer Conferences
A multicenter phase II study of bevacizumab (B) and temsirolimus (T) in women with recurrent epithelial ovarian cancer (OC): A study of the Mayo, Chicago, California, New York, Southeast, and Princess Margaret Phase II Consortia Conferences
A phase I study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) plus platinum-based doublet chemotherapy (PT-doublet) in chemotherapy-naive non-small cell lung cancer (NSCLC) patients (pts) Conferences
A phase I, dose-escalation trial of continuous and pulsed-dose afatinib (A) combined with pemetrexed (P) in patients (pts) with advanced solid tumors: Final analysis. Conferences
A phase II multicenter study of the efficacy and safety of sunitinib given on an individualized schedule as first-line therapy for metastatic renal cell cancer. Conferences
A phase III study of the impact of a physical activity program on disease-free survival in patients with high-risk stage II or stage III colon cancer: A randomized controlled trial (NCIC CTG CO.21) Conferences
A randomized phase II study of cediranib (CED) alone versus CED plus dasatinib (DAS) in patients (pts) with castration-resistant prostate cancer (CRPC). Conferences
A randomized trial of single versus multiple fractions (Fx) for re-irradiation (RE-RT) of painful bone metastases (PBM): NCIC CTG SC.20. Conferences
Bowel obstruction with stage IV cancer: The benefit of introduction of formal palliative care service. Conferences
Canadian ALK (CALK): A pan-Canadian multicenter study to optimize and standardize ALK immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) for ALK gene rearrangements Conferences
Cancer Care Ontario's lung disease pathway initiative: Building resources for lung cancer quality care Conferences
Characteristics of clinical trials for adolescent and young adult (AYA) cancer patients (pts) in Ontario. Conferences
Clinical impact of EGFR mutation fraction and tumor cellularity in EGFR mutation positive NSCLC. Conferences
Cochrane systematic review and meta-analysis of adjuvant chemotherapy for stage II colon cancer Conferences
Competing risks of death in NCIC CTG MA.27 adjuvant exemestane versus anastrozole. Conferences
Design of the AFFINITY study: A randomized phase III study of a novel clusterin inhibitor, custirsen, plus cabazitaxel/prednisone (CbzP) versus CbzP alone as second-line chemotherapy in metastatic castration-resistant prostate cancer (mCRPC). Conferences
Development of a practice consensus statement of the management of locally advanced breast cancer: Expert consensus and systematic review. Conferences
Effect of metformin versus placebo on weight and metabolic factors in initial patients enrolled onto NCIC CTG MA.32, a multicenter adjuvant randomized controlled trial in early-stage breast cancer (BC) Conferences
Effective routine electronic symptom screening and use of evidence to improve cancer symptom management in Ontario, Canada. Conferences
Evaluation of potential predictive markers of efficacy of dacomitinib in patients (pts) with recurrent/metastatic SCCHN from a phase II trial Conferences
Final efficacy results of NCIC CTG IND.202: A randomized phase II study of recombinant interleukin-21 (rIL21) in patients with recurrent or metastatic melanoma (MM) Conferences
Final results of a phase I study evaluating the combination of linsitinib, a dual inhibitor of insulin-like growth factor-1 receptor (IGF-1R), and insulin receptor (IR) with weekly paclitaxel (PAC) in patients (Pts) with advanced solid tumors. Conferences
First-in-class, first-in-human phase I trial of KPT-330, a selective inhibitor of nuclear export (SINE) in patients (pts) with advanced solid tumors. Conferences
Identification of knowledge translation opportunities in the treatment of locally advanced breast cancer: Results of a national survey of physicians Conferences
Impact of response to prior chemotherapy (RTPC) on outcomes in second-line therapy for advanced urothelial carcinoma (UC): Implications for trial design. Conferences
Impact of wait times on survival of women with uterine cancer. Conferences
Interim safety results of a global early access protocol (EAP) of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after taxane-based chemotherapy Conferences
NCIC CTG, IND-205: A phase II study of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer (CRPC). Conferences
Nomogram to estimate the activity of second-line therapy for advanced urothelial carcinoma (UC) Conferences
Ovarian cancer distribution of histology, stage, and screening performance Conferences
Perioperative epidural analgesia and recurrence-free survival for ovarian cancer surgery: A retrospective analysis. Conferences
Phase I trial of trebananib (AMG 386) plus temsirolimus (Tr plus T) in patients (pts) with advanced solid tumors (PJC-008/NCI#9041) Conferences
Prevalence, risk factors, treatment and outcomes of catheter-related thrombosis in patients with malignancies. Conferences
Randomized phase II placebo-controlled trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone receptor-positive metastatic breast cancer (MBC): OCOG Zamboney study-NCT00811369. Conferences
Rapid assessment of frailty prior to treatment of elderly colorectal cancer patients. Conferences
Real-time clinical application of next-generation sequencing (NGS): Results from a multicenter program Conferences
Reasons for delay in time to initiation of adjuvant chemotherapy (AC) for colon cancer (CC). Conferences
Results from a structured interprofessional palliative care rehabilitation program in oncology. Conferences
Risk and predictors of suicide in colorectal cancer patients: A SEER analysis Conferences
Screening for Lynch syndrome in unselected women with endometrial cancer Conferences
Simulating the cost-effectiveness of lung cancer screening by low-dose CT scan in Canada Conferences
Switching patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) with residual disease on long-term imatinib (IM) to nilotinib (NIL): ENESTcmr 24-mo follow-up Conferences
The effect of surgery type on survival and recurrence in very young women with breast cancer. Conferences
The first 10 years experience with genetic testing (GT) for BRCA1/2 mutations in a publicly funded program at a tertiary care teaching hospital in Ontario, Canada Conferences
The role of FSH in castration-induced adipogenesis: Highlighting differences between orchiectomy, GNRH agonists, and antagonists. Conferences
Thrombotic events in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab. Conferences
Toward integration of palliative care into cancer care: A study on profile of psychosocial and clinical complications among attendees of a Nigerian oncological center. Conferences
Weekly vinblastine in chemotherapy-naive children with unresectable or progressive low grade glioma: A Canadian cooperative study Conferences